Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$11.5 million.

  • Rapid Micro Biosystems' Net Income towards Common Stockholders fell 160.73% to -$11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 847.81%. This contributed to the annual value of -$46.9 million for FY2024, which is 1063.14% up from last year.
  • Per Rapid Micro Biosystems' latest filing, its Net Income towards Common Stockholders stood at -$11.5 million for Q3 2025, which was down 160.73% from -$11.9 million recorded in Q2 2025.
  • Rapid Micro Biosystems' Net Income towards Common Stockholders' 5-year high stood at -$9.7 million during Q4 2024, with a 5-year trough of -$25.2 million in Q3 2021.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$13.4 million (2023), whereas its average is -$14.4 million.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Net Income towards Common Stockholders crashed by 13557.76% in 2021, and later soared by 3855.71% in 2022.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Net Income towards Common Stockholders stood at -$14.6 million in 2021, then dropped by 12.61% to -$16.4 million in 2022, then skyrocketed by 32.07% to -$11.2 million in 2023, then rose by 13.48% to -$9.7 million in 2024, then fell by 19.03% to -$11.5 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$11.5 million for Q3 2025, versus -$11.9 million for Q2 2025 and -$11.3 million for Q1 2025.